Trial
NCT00030056
GM-CSF in Patients With Pulmonary Alveolar Proteinosis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Cleveland Clinic
Collaborators
—
Condition
Pulmonary Alveolar Proteinosis
Intervention
GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-25